Schedule 13D ownership disclosure
MILESTONE PHARMACEUTICALS IN
Security class unavailable · CUSIP: 59935V107
Event date: 2019-11-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-302384
- Form type
- SC 13D
- Filer
- Milestone Pharmaceuticals Inc.
- CIK
- CIK 1408443
- Filed
- Nov 27, 2019
- Reporting period
- Nov 25, 2019
- Description
- Schedule 13D beneficial ownership